These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 8290015)

  • 41. Treatment with recombinant human erythropoietin in patients with aluminum overload and hyperparathyroidism.
    Grützmacher P; Ehmer B; Limbach J; Messinger D; Kulbe KD; Scigalla P
    Blood Purif; 1990; 8(5):279-84. PubMed ID: 2091687
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Modified method of determining delta-aminolevulinic acid dehydratase activity in erythrocytes].
    Semenova LS
    Lab Delo; 1985; (11):687-8. PubMed ID: 2417026
    [No Abstract]   [Full Text] [Related]  

  • 43. Nutritional assessment in anemic hemodialysis patients treated with recombinant human erythropoietin.
    Bárány P; Pettersson E; Ahlberg M; Hultman E; Bergström J
    Clin Nephrol; 1991 Jun; 35(6):270-9. PubMed ID: 1873941
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of aluminum on porphyrin metabolism in hemodialyzed patients.
    Buchet JP; Lauwerys R; Hassoun A; Dratwa M; Wens R; Collart F; Tielemans C
    Nephron; 1987; 46(4):360-3. PubMed ID: 3658064
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [An echocardiographic study of the left ventricular functional indices in pediatric patients on hemodialysis and in treatment with recombinant human erythropoietin (r-HuEPO)].
    Seracini D; Pollini I; Lavoratti GC; Pela I; Materassi M; Danti D; De Simone L; Favilli S; Manetti A
    Pediatr Med Chir; 1994; 16(4):389-92. PubMed ID: 7816703
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Preventive effects of recombinant human erythropoietin administration on anemia associated with repeated hemodialysis in nephrectomized dogs.
    Oishi A; Hamada S; Sakamoto H; Shimizu R
    J Vet Med Sci; 1995 Oct; 57(5):989-90. PubMed ID: 8593322
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Human recombinant erythropoietin treatment in transfusion dependent anemic patients on maintenance hemodialysis.
    Zehnder C; Blumberg A
    Clin Nephrol; 1989 Feb; 31(2):55-9. PubMed ID: 2920469
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Countermeasure for patients with anemia due to hemodialysis].
    Suzuki M
    Nihon Naika Gakkai Zasshi; 1995 Oct; 84(10):1663-7. PubMed ID: 8537721
    [No Abstract]   [Full Text] [Related]  

  • 49. Porphobilinogen synthase (delta-aminolevulinic acid dehydratase) activity in human erythrocytes: reactivation by zinc and dithiothreitol depending on influence of storage.
    Geisse S; Brüller HJ; Doss M
    Clin Chim Acta; 1983 Dec; 135(2):239-45. PubMed ID: 6652929
    [No Abstract]   [Full Text] [Related]  

  • 50. [Improvement of hemorheologic parameters in hemodialyzed patients treated with human recombinant erythropoietin].
    Delamaire M; Durand F; Hamel D; Joyeux V; Lepogamp P; Genetet B
    J Mal Vasc; 1991; 16(3):289-94. PubMed ID: 1940657
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [A new method for the determination of delta-aminolevulinic acid dehydratase activity. Various measuring problems].
    Berkó G; Durkó I
    Z Med Lab Diagn; 1977 Apr; 18(2):117-22. PubMed ID: 883361
    [No Abstract]   [Full Text] [Related]  

  • 52. [Comparative study of methods for measurements of erythrocyte aminolevulinic acid dehydratase activity].
    Trevisan A; Buzzo A; Scarpa FM
    Med Lav; 1981; 72(2):113-7. PubMed ID: 7242450
    [No Abstract]   [Full Text] [Related]  

  • 53. [Significance of delta-aminolevulinic acid dehydratase analysis in clinical tests].
    Sassa S
    Nihon Rinsho; 1989 Dec; 48 Suppl():694-7. PubMed ID: 2621984
    [No Abstract]   [Full Text] [Related]  

  • 54. [Erythrocyte delta-aminolevulinic dehydratase and protoporphyrin in lead exposure].
    Oyanguren C; Oyanguren H; Guzmán E; Vega F; Labarca J
    Rev Med Chil; 1982 May; 110(5):439-43. PubMed ID: 7163680
    [No Abstract]   [Full Text] [Related]  

  • 55. Clinical experience with recombinant human erythropoietin in hemodialysis patients.
    Schaefer RM; Kuerner B; Zech M; Heidland A
    Pol Arch Med Wewn; 1988 Oct; 80(4):213-20. PubMed ID: 3078210
    [No Abstract]   [Full Text] [Related]  

  • 56. Red cell membrane during erythropoietin therapy in hemodialysis and in hemodiafiltration.
    Icardi A; Paoletti E; Traverso GB; Sarchi C; Cappelli G; Molinelli G
    Int J Artif Organs; 1991 Mar; 14(3):147-9. PubMed ID: 2045188
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Erythrocyte vitamins B1, B2 and B6 and erythropoietin.
    Mydlik M; Derzsiová K
    Am J Nephrol; 1993; 13(6):464-6. PubMed ID: 8141181
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Changes in blood levels of aminolevulinic acid dehydratase enzyme activity in various forms of anemia and secondary polycythemia].
    Rubio Pérez P; Sánchez Sánchez ML; Lucena Marotta F; Santalla Peciña F; Millán Nuñez-Córtes J; Calvo Manuel E; Espinós Pérez D
    Rev Clin Esp; 1981 Oct; 163(2):91-4. PubMed ID: 7330349
    [No Abstract]   [Full Text] [Related]  

  • 59. [Reactivation level of erythrocyte delta-aminolevulinic acid dehydratase: an indicator of the degree of lead absorption].
    Dumas D; Brodeur J; P'an A
    Union Med Can; 1981 May; 110(5):421-6. PubMed ID: 7256992
    [No Abstract]   [Full Text] [Related]  

  • 60. [Comparison of the activity values of delta-aminolevulinic acid dehydratase in human erythrocytes, as measured by three different methods (author's transl)].
    Tomokuni K
    Nihon Eiseigaku Zasshi; 1981 Feb; 35(6):864-8. PubMed ID: 7289177
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.